首页 | 本学科首页   官方微博 | 高级检索  
     

慢性阻塞性肺疾病患者血清和痰液中表面活性蛋白D的水平及临床意义
引用本文:段艳红,杜春玲,肖建,周锋,徐栋辉,吴超民,周磊. 慢性阻塞性肺疾病患者血清和痰液中表面活性蛋白D的水平及临床意义[J]. 中国临床医学, 2014, 0(5): 537-539
作者姓名:段艳红  杜春玲  肖建  周锋  徐栋辉  吴超民  周磊
作者单位:复旦大学附属中山医院青浦分院呼吸内科,上海,201700
摘    要:目的:探讨慢性阻塞性肺疾病(chronic obstructive pulmonary disease,AECOPD)患者血清和痰液中表面活性蛋白D(surfactant protein D,SP-D)的水平和临床意义。方法:选取急性加重期COPD(acute exacerbation of COPD,AECOPD)患者34例(A组)、稳定期COPD患者37例(B组)、有嗜烟史的健康人30例(C组)、无嗜烟史的健康人30例(D组)。分别检测4组血清和痰液中的SP-D水平,并分析AECOPD患者血清和痰液SP-D水平的相关性。结果:A、B、C、D组的血清SP-D水平依次为(165.09±16.72)、(126.48±15.64)、(72.85±8.62)、(54.70±7.29)ng/mL,痰液SP-D水平依次为(109.03±18.95)、(133.28±16.36)、(260.04±47.91)、(665.89±117.49)ng/mL;血清和痰液SP-D水平在4组间的差异均有统计学意义(P0.05)。AECOPD患者的血清SP-D水平和痰液SP-D水平呈负相关(r=-0.698,P0.05)。结论:AECOPD患者的血清、痰液SP-D水平呈负相关。血清、痰液SP-D水平的监测有助于临床AECOPD病情的评估。

关 键 词:慢性阻塞性肺疾病  急性加重期  肺表面活性蛋白D

Serum and Sputum Levels of Surfactant Protein D in Patients with Chronic Obstructive Pulmonary Disease and the Clinical Significance
DUAN Yanhong,DU Chunling,XIAO Jian,ZHOU Feng,XU Donghui,WU Chaomin,ZHOU Lei. Serum and Sputum Levels of Surfactant Protein D in Patients with Chronic Obstructive Pulmonary Disease and the Clinical Significance[J]. Chinese Journal Of Clinical Medicine, 2014, 0(5): 537-539
Authors:DUAN Yanhong  DU Chunling  XIAO Jian  ZHOU Feng  XU Donghui  WU Chaomin  ZHOU Lei
Affiliation:(Department of Respiratory Disease,Qingpu Branch of Zhongshan Hospital, Fudan University ,Shanghai 201700, China)
Abstract:Objective:To explore the levels and clinical significance of serum and sputum surfactant protein D (SP-D)in pa-tients with chronic obstructive pulmonary disease (AECOPD).Methods:Thirty-four patients with AECOPD (Group A),37 patients with stable COPD (Group B),30 healthy people with smoking history (Group C),and 30 helthy people without smok-ing history (Group D)were enrolled.SP-D levels in the serum and sputum of the four groups were detected and compared. Moreover,the correlation between serum SP-D level and sputum SP-D level in patients with AECOPD was analyzed.Results:The serum SP-D levels in Group A,Group B,Group C and Group D were (165.09±16.72)ng/mL,(126.48± 15.64)ng/mL, (72.85±8.62)ng/mL and(54.70±7.29)ng/mL,respectively.The sputum SP-D levels in Group A,Group B,Group C and Group D were (109.03 ± 18.95)ng/mL,(133.28± 16.36)ng/mL,(260.04±47.91)ng/mL and(665.89± 117.49)ng/mL. There were significant differences in the levels of serum and sputum SP-D among the four groups(P 〈0.05).Serum SP-D level and sputum SP-D level in patients with AECOPD were negatively correlated (r=-0.698,P 〈0.05).Conclusions:The detec-tion of SP-D levels in serum and sputum contributes to the clinical assessment of AECOPD.There is a negative correlation be-tween serum SP-D level and sputum SP-D level in AECOPD patients.
Keywords:Chronic obstructive pulmonary disease  Acute exacerbation  Surfactant protein D
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号